23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.13%
Negative revenue growth while Insurance - Life median is 2.28%. Seth Klarman would investigate if the company is losing market share or facing a declining industry.
-6.13%
Negative gross profit growth while Insurance - Life median is 2.83%. Seth Klarman would suspect poor product pricing or inefficient production.
54.15%
EBIT growth of 54.15% while Insurance - Life median is zero. Walter Schloss would see a marginal edge that could be expanded upon.
54.15%
Positive operating income growth while Insurance - Life is negative. Peter Lynch would spot a big relative advantage here.
83.73%
Net income growth of 83.73% while Insurance - Life median is zero. Walter Schloss might see potential if moderate gains can keep rising.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
12.02%
OCF growth of 12.02% while Insurance - Life is zero. Walter Schloss might see a modest positive difference, which can compound over time.
12.02%
FCF growth of 12.02% while Insurance - Life median is zero. Walter Schloss might see a slight edge that could compound over time.
37.75%
10Y revenue/share CAGR 75-90% of Insurance - Life median of 45.47%. John Neff would seek operational improvements to catch up with peers.
8.25%
Below 50% of Insurance - Life median. Jim Chanos would suspect structural disadvantages or a higher share base limiting per-share growth.
-50.01%
Negative 3Y CAGR while Insurance - Life median is 0.00%. Seth Klarman would examine if the sector is otherwise stable, indicating a company-specific issue.
268.90%
OCF/share CAGR exceeding 1.5x Insurance - Life median of 29.62% over 10 years. Joel Greenblatt would verify if a unique competitive moat underlies these cash flows.
30.24%
OCF/share CAGR of 30.24% while Insurance - Life median is zero. Walter Schloss might see a slight advantage that can compound if momentum builds.
-0.55%
Negative 3Y OCF/share CAGR while Insurance - Life median is 2.68%. Seth Klarman would check whether it’s cyclical or a firm-specific problem.
31.00%
Net income/share CAGR of 31.00% while Insurance - Life median is zero. Walter Schloss might see a marginal edge that can grow if the firm invests wisely.
475.82%
5Y net income/share CAGR > 1.5x Insurance - Life median of 9.30%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
-1.23%
Negative 3Y CAGR while Insurance - Life median is -18.09%. Seth Klarman might see a pressing concern if the rest of the sector is stable or growing.
65.04%
Equity/share CAGR 1.25-1.5x Insurance - Life median. Mohnish Pabrai might credit disciplined reinvestment or conservative payout ratios for outperformance.
2.69%
5Y equity/share CAGR 50-75% of Insurance - Life median. Guy Spier sees subpar net worth creation vs. competitors.
-8.25%
Negative 3Y equity/share growth while Insurance - Life median is -13.18%. Seth Klarman sees a short-term weakness if peers still expand net worth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
4.75%
Asset growth near Insurance - Life median. Charlie Munger attributes it to a typical industry cycle of capital investment.
No Data
No Data available this quarter, please select a different quarter.
-1.45%
Debt is shrinking while Insurance - Life median is rising. Seth Klarman might see an advantage if growth remains possible.
No Data
No Data available this quarter, please select a different quarter.
13.24%
SG&A growth far above Insurance - Life median. Jim Chanos sees potential red flags in cost management or diminishing returns on spending.